CO40 Impact of Long-Acting Modality on Health Technology Assessments and Formulary Decision Making in the EU4 and USA
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.114
https://www.valueinhealthjournal.com/article/S1098-3015(23)00214-0/fulltext
Title :
CO40 Impact of Long-Acting Modality on Health Technology Assessments and Formulary Decision Making in the EU4 and USA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00214-0&doi=10.1016/j.jval.2023.03.114
First page :
Section Title :
Open access? :
No
Section Order :
10580